Clinical Trials on Gaucher Disease, Type III in Belgium

Total 1823 results

Comunicare Solutions SA
KU Leuven; Jessa Hospital; Cliniques universitaires Saint-Luc- Université Catholique... and other collaborators

Recruiting

Implementation and Cost-evaluation of a Smartphone-based Telemonitoring and Digital Support in Patients With HF (BEDICARE-HF)

Heart Failure | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IV

Belgium
Idorsia Pharmaceuticals Ltd.

Completed

Natural History Study for Pediatric Patients With Early Onset of Either GM1 Gangliosidosis, GM2 Gangliosidoses, or Gaucher Disease Type 2 (RETRIEVE)

GM2 Gangliosidosis | GM1 Gangliosidosis | Tay-Sachs Disease | Sandhoff Disease | Gaucher Disease, Type 2 | AB Variant Gangliosidosis GM2

United States, Spain, Germany, Italy, Belgium, Brazil, France, Portugal, Switzerland, United Kingdom
University Hospital, Ghent
Centre Hospitalier Universitaire Vaudois; University Ghent; Hopital Lariboisière and other collaborators

Completed

PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian Cancer (PIPAC-nabpac)

Breast Cancer Stage IV | Peritoneal Carcinomatosis | Ovarian Cancer Stage IIIC | Ovarian Cancer Stage IV | Breast Cancer Stage IIIB | Breast Cancer Stage IIIc | Ovarian Cancer Stage IIIB | Stomach Cancer Stage III | Stomach Cancer Stage IV With Metastases | Pancreas Cancer, Stage III | Pancreas Cancer, Stage...

Belgium
Alexion Pharmaceuticals
Achillion, a wholly owned subsidiary of Alexion

Completed

A Proof-of-Mechanism Study to Determine the Effect of Danicopan on C3 Levels in Participants With C3G or IC-MPGN

C3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Mediated Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis Types I, II, and III

Netherlands, Australia, Belgium
Celyad Oncology SA

Completed

C-Cure Clinical Trial

Heart Failure Class II or III

Belgium, Serbia
Universitair Ziekenhuis Brussel

Recruiting

A Clinical Trial of Regorafenib in Patients With Pretreated Advanced Melanoma (RegoMel)

Melanoma Stage IV | Melanoma Stage III

Belgium
Universitair Ziekenhuis Brussel

Completed

TraMel-WT: A Trial of Trametinib in Patients With Advanced Pretreated BRAFV600 Wild-type Melanoma (TraMel-WT)

Stage IV Melanoma | Stage III Melanoma

Belgium
Cliniques universitaires Saint-Luc- Université...
Université Catholique de Louvain

Completed

Effect of a Specific Aquaporin-1 Inhibitor on Vascular Oxidative Stress in Healthy Volunteers (Bacoxy_II)

Cardiovascular Diseases | Endothelial Dysfunction | Oxidative Stress | Bacopaside II | Bacopa Monnieri | Aquaporin 1 | AQP1

Belgium
Bart Neyns
Vrije Universiteit Brussel

Completed

Autologous TriMix-DC Therapeutic Vaccine in Combination With Ipilimumab in Patients With Previously Treated Unresectable Stage III or IV Melanoma (TriMix-Ipi)

Malignant Melanoma Stage III | Malignant Melanoma Stage IV

Belgium
Universitair Ziekenhuis Brussel
RIZIV

Completed

mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma (DC-MEL)

Malignant Melanoma Stage III | Malignant Melanoma Stage IV

Belgium
Hoffmann-La Roche
Association Française contre les Myopathies (AFM), Paris

Completed

Safety and Efficacy of Olesoxime (TRO19622) in 3-25 Years SMA Patients.

Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy Type III Non Ambulant

Germany, Italy, France, Belgium, Poland, Netherlands, United Kingdom
Endotronix, Inc.

Active, not recruiting

SIRONA Trial Heart Failure NYHA Class III

Heart Failure NYHA Class III

Belgium, Ireland
Pfizer

Completed

Single Dose Escalation Study of PF-05190457 in Healthy Volunteers

Diabetes Mellitus, Type II

Belgium
Jules Bordet Institute

Recruiting

Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer (REGINA)

Rectal Cancer Stage II | Rectal Cancer Stage III

Belgium, France
Endotronix, Inc.

Active, not recruiting

SIRONA 2 Trial Heart Failure NYHA Class III

Heart Failure NYHA Class III

Ireland, Belgium, Germany
Universitair Ziekenhuis Brussel

Not yet recruiting

Belgian Antithrombin Deficiency Registry

Antithrombin III Deficiency

Belgium
Ziekenhuis Oost-Limburg

Unknown

Effect of Bone-anchored Protraction on Maxillary Growth in the Young Child

Maxillary Hypoplasia | Malocclusion, Angle Class III

Belgium
Universitair Ziekenhuis Brussel

Completed

A Clinical Trial: Adjuvant Low-dose Ipilimumab + Nivolumab After Resection of Melanoma Macrometastases (ipniv)

Stage IV Skin Melanoma | Stage IIIC Skin Melanoma

Belgium
Universitaire Ziekenhuizen KU Leuven
KU Leuven

Completed

Proof of Concept - Identification of Patient-specific Parameters for Bolus Calculators for Type 1 Diabetes (POC-IDENTITY-1)

Type1 Diabetes Mellitus

Belgium
Jessa Hospital

Completed

Comparison Between Enlite and Flash Glucose Monitoring

Type1 Diabetes Mellitus

Belgium
European Organisation for Research and Treatment...
Breast International Group; Menarini Group

Recruiting

Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA) (TREAT ctDNA)

Stage IIB Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | Stage III Breast Cancer

Belgium, Italy, Ireland, France, Germany
Ziekenhuis Oost-Limburg
Ziekenhuis Oost-Limburg

Recruiting

Characteristics of NAFLD Among Type 2 Diabetes Patients

Type2 Diabetes | Non-Alcoholic Fatty Liver Disease

Belgium
European Organisation for Research and Treatment...
Pfizer; ETOP IBCSG Partners Foundation; UNICANCER; Breast International Group; SOLTI... and other collaborators

Active, not recruiting

Adjuvant Palbociclib in Elderly Patients With Breast Cancer (Appalaches)

Breast Cancer Stage II | Breast Cancer Stage III

Spain, France, Italy, Belgium, Jordan, Poland, Germany, United Kingdom, Portugal
Hasselt University
Jessa Hospital

Completed

Effect of High-intensity Interval Training on Cardiac Function and Regulation of Glycemic Control in Diabetic Cardiomyopathy

Type2 Diabetes | Diabetic Cardiomyopathies

Belgium
University Hospital, Essen

Recruiting

Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients (NEOpredict)

NSCLC, Stage I | NSCLC Stage II | NSCLC, Stage IIIA

Belgium, Germany, Netherlands
Hasselt University
Ziekenhuis Oost-Limburg

Completed

Metabolomics Predict Therapy Response (PROLUNG)

NSCLC, Stage IIIA

Belgium
AZ Sint-Jan AV

Recruiting

Validation of the O-bridge Protocol: a Prospective, Multicenter Trial

Quality of Life | Mandibular Reconstruction | Benign or Malignant Tumour of the Oral Cavity | Stage III-IV Osteonecrosis | Fixed Dental Restoration

Belgium
Universitair Ziekenhuis Brussel
Juvenile Diabetes Research Foundation; Vrije Universiteit Brussel

Recruiting

Continuous Monitoring of Glycemic Variability to Predict Dys- and Hyperglycemia in Asymptomatic Type 1 Diabetes

Type1 Diabetes Mellitus

Belgium
Leiden University Medical Center
Jessa Hospital; The Netherlands Cancer Institute

Recruiting

Response and Toxicity Prediction by Microbiome Analysis After Concurrent Chemoradiotherapy (Prediction)

Immunotherapy | Non Small Cell Lung Cancer Stage III

Netherlands, Belgium
Cliniques universitaires Saint-Luc- Université...

Unknown

Impact of Changes in Muscle Secretome in the Remission of Type 2 Diabetes Mellitus Induced by Bariatric Surgery (MYDIASECRET)

Diabete Type 2

Belgium
Novartis Gene Therapies

Active, not recruiting

Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi

SMA | Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy Type I | Spinal Muscular Atrophy Type III

United States, Belgium, France, Japan, United Kingdom, Italy, Taiwan, Australia, Canada
Cliniques universitaires Saint-Luc- Université...

Completed

Effect of Oral Intake of Bacopa Monneiri on Vascular Oxidative Stress (Bacoxy_I)

Cardiovascular Diseases | Endothelial Dysfunction | Oxidative Stress | Bacopaside II | Bacopa Monnieri | Aquaporin 1 | AQP1

Belgium
University Hospital, Ghent
University Ghent

Completed

Effects of Postprandial Exercise on Glycaemia and Metabolism in People With Type 1 Diabetes (PRANDEX-1)

Type 1 Diabetes Mellitus

Belgium
Cliniques universitaires Saint-Luc- Université...

Withdrawn

Safety and Efficacy Study of Encapsulated Human Islets Allotransplantation to Treat Type 1 Diabetes

Type 1 Diabetes Mellitus

Belgium
University Ghent

Completed

Identifying the Effect and Working Mechanisms of MyPlan 2.0 in Adults With Type 2 Diabetes

Chronic Disease

Belgium
University of Liege
EGID, Lille

Unknown

Research Study for Rare Pathogenic Mutations Causing Type 2 Diabetes and Complications (PreciDiag)

Diabete Type 2

Belgium
University Ghent
BOF

Completed

Controlled Outcome Evaluations of a Daily Physical Activity Intervention for Individuals With Type 2 Diabetes

Type 2 Diabetes

Belgium
Centre Hospitalier Universitaire de Liege
Sanofi; Takeda; University of Liege; Orchard Therapeutics; Centre Hospitalier Régional... and other collaborators

Recruiting

Baby Detect : Genomic Newborn Screening

Congenital Adrenal Hyperplasia | Hemophilia A | Hemophilia B | Mucopolysaccharidosis I | Mucopolysaccharidosis II | Cystic Fibrosis | Alpha 1-Antitrypsin Deficiency | Sickle Cell Disease | Fanconi Anemia | Chronic Granulomatous Disease | Wilson Disease | Severe Congenital Neutropenia | Ornithine Transcarbamylase... and other conditions

Belgium
University Ghent

Completed

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

Diabetes Mellitus

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Effect of Exenatide on Glucose Homeostasis Determinants in Type 2 Diabetes

Type 2 Diabetes Mellitus

Belgium
BioNTech SE

Recruiting

Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy

Colorectal Cancer Stage II | Colorectal Cancer Stage III

United States, Spain, Germany, Belgium
Erasme University Hospital

Terminated

Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.

Type 2 Diabetes | Pancreas | Incretinomimetics

Belgium
prof dr Pieter Gillard
University Colleges Leuven Limburg

Recruiting

The Integration of Physical Activity Into the Clinical Decision Process of People With Type 1 Diabetes (ENHANCED1)

Type 1 Diabetes

Belgium
Queen Fabiola Children's University Hospital

Unknown

Prospective Randomized Clinical Trial Assessing the Short Term Clinical Impact of Continuous vs Flash Glucose Monitoring in Children, Adolescents and Young Adults With Type 1 Diabetes (GluMoCAY)

Type 1 Diabetes

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Evaluation of Glycemic Changes During Exercise in Children With Type 1 Diabetes (TREAD-DIAB)

Type 1 Diabetes

Belgium
Université Catholique de Louvain
Fonds National de la Recherche Scientifique; BESPEED

Active, not recruiting

Phenotypic and Genotypic Characterization of New-onset Type I Diabetes (DIATAG)

Type1diabetes

Belgium
University Hospital, Antwerp

Recruiting

Validation of a 13C Glucose Breath Test Compared With the Euglycaemic Clamp Test (BRECLAIR)

Insulin Resistance | Type 1 Diabetes

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Risk for Ketonaemia in Type 1 Diabetes Pregnancies With Sensor-augmented Pump Therapy (ROKSANA)

Pregnant Women With Type 1 Diabetes

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients

Psoriasis | Type 2 Diabetes

Belgium
Universitaire Ziekenhuizen KU Leuven

Unknown

External ValidatIon Trial of ASTER Trial (EVITA)

Stage III Lung Cancer

Belgium

Clinical Trials on Gaucher Disease, Type III in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations